※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
07:30-08:10
- Satellite Symposium 2
-
- Venue:
- Halla Hall
- Dose Intensity and the Importance of Febrile Neutropenia Prevention
- Yeon Hee Park (Samsung Medical Center, Korea)Slide ViewVideo ViewAbstract
08:30-09:30
- Plenary Lecture 3
-
- Venue:
- Halla Hall
09:40-10:50
- Symposium 2:
- Immuno-oncology - Where We Are?
- Venue:
- Halla Hall
- Immune Check-point Blockade for Breast Cancer
- Peter Schmid (Barts Cancer Institute, Queen Mary Univ. of London, United Kingdom)
- Immune Approaches to the Treatment of Breast Cancer, around the Corner?
- Yasir Nagarwala (Merck & Co., Inc., U.S.A.)Video ViewAbstract
- Immune Monitoring for Immuno-oncology Clinical Trials
- Mary L. Disis (Univ. of Washington, U.S.A.)Slide ViewVideo View
- Invited Oral Presentation
-
- Venue:
- Lotus Hall
- SUBGROUP ANALYSIS OF ASIAN POPULATION AMONG PALOMA-2 TRIALS
- In Hae Park (National Cancer Center, Korea)Abstract
- FIRST-LINE RIBOCICLIB + LETROZOLE IN POSTMENOPAUSAL ASIAN WOMEN WITH HORMONE RECEPTOR-POSITIVE (HR+), HER2-NEGATIVE (HER2-) ADVANCED BREAST CANCER (ABC): A SUBGROUP ANALYSIS OF MONALEESA-2
- Yoon Sim Yap (National Cancer Centre Singapore, Singapore)Slide ViewVideo ViewAbstract
- BREAST MRI MONITORING FOR YOUNG BREAST CANCER PATIENTS AFTER BREAST CONSERVATION THERAPY: A MULTICENTER PROSPECTIVE STUDY
- Woo Kyung Moon (Seoul National Univ. Hospital, Korea)Abstract
- A PROSPECTIVE, RANDOMIZED, MULTICENTER, OPEN-LABEL PHASE III NEOADJUVANT STUDY TO COMPARE CHEMOTHERAPY WITH ENDOCRINE THERAPY IN PREMENOPAUSAL PATIENTS WITH HORMONE RECEPTOR POSITIVE, HER2 NEGATIVE BREAST CANCER
- Hee-Jeong Kim (ASAN Medical Center, Korea)Slide ViewVideo ViewAbstract
11:00-12:10
- Symposium 3:
- Young Age Session
- Venue:
- Halla Hall
- Education Session 2:
- Mutational Landscape and Its Implications for Treatment of Breast Cancer
- Venue:
- Lotus Hall
- Overcoming Heterogeneity: Single Cell Sequencing of Breast Cancer
- Wonshik Han (Seoul National Univ. Hospital, Korea)Slide ViewVideo ViewAbstract
- Practical Implications of Next Generation Sequencing in Breast Cancer: Promises and Challenges
- Naoto Ueno (The Univ. of Texas, MD Anderson Cancer Center, U.S.A.)Slide ViewVideo ViewAbstract
- Molecular Heterogeneity of Triple-negative Breast Cancer
- Katherine A. Hoadley (On behalf of Prof. Charles M. Perou) (Univ. of North Carolina at Chapel Hill, U.S.A.)Slide ViewVideo ViewAbstract
12:10-13:10
- Satellite Symposium 3
-
- Venue:
- Halla Hall
13:30-14:30
- Plenary Lecture 4
-
- Venue:
- Halla Hall
13:30-15:10
- Nursing Session:
- Management of Metastatic, Recurrent and Intractable Breast Cancer
- Venue:
- Weolla Room
- Survivorship Issues of the Metastatic, Recurrent and Intractable Breast Cancer
- Yaelim Lee (Chung-Ang Univ., Korea)Slide ViewAbstract
- Nursing Care in Bone Metastasis
- Hyejin Cho (Ewha Womans Univ. Mokdong Hospital, Korea)Slide ViewAbstract
- Nursing Care in Visceral Metastasis
- Seung Hee Seon (Korea Univ. Guro Hospital, Korea)Slide ViewAbstract
- Specialist Nursing Roles for the Patient with Metastatic, Recurrent and Intractable Breast Cancer
- Su jin Lee (Dankook Univ. Hospital, Korea)Slide ViewAbstract
- Complementary and Alternative Therapies
- Eun-Young Jun (DaeJeon Univ., Korea)Slide ViewAbstract
14:30-15:50
- ABRCA & HBOC
-
- Venue:
- Lotus Hall
- Breast Cancer Genetics - How Is It Changing Our Practice
- Ava Kwong (The Univ. of Hong Kong, Hong Kong)Slide ViewVideo ViewAbstract
- Panel Testing and SNP Testing (Polygenic Risk Score) in Asian Women
- Soo-Hwang Teo (Cancer Research Malaysia, Malaysia)Slide ViewVideo ViewAbstract
- Breast Cancer Genetics and Cancer Policy
- Steven A Narod (Women's College Research Institute, Women's College Hospital, Dalla Lana School of Public Health, Univ. of Toronto, Canada)Slide ViewVideo ViewAbstract
- Genetic Susceptibility to Breast Cancer: Roles of High-moderate and Modest-penetrance Alleles
- David Goldgar (Univ. of Utah School of Medicine, U.S.A.)Abstract
14:40-15:50
- Symposium 4:
- Challenges in the Implementation of Biosimilar: New Frontiers in Oncology
- Venue:
- Halla Hall
16:00-17:10
- Panel Discussion 3:
- Minimizing Local Therapy
- Venue:
- Halla Hall
- Panel Discussion 4:
- Role of Imaging in the Era of ALND Omitting of N1 Breast Cancer
- Venue:
- Lotus Hall
16:00-17:20
- ABC Networking Business Meeting
-
- Venue:
- Weolla Room
- ABCN Collaborative Group
- Young-Jin Suh (The Catholic Univ. of Korea, St. Vincent's Hospital, Korea)
- ABCN Mentorship
- Tae Hyun Kim (Inje Univ. Busan Paik Hospital, Korea)
- Wisdom Sharing: Foundation, Establishment, and Development of BIG
- Martine Piccart (Institut Jules Bordet, Belgium)
- Clinical Trail Collaboration across and beyond Asia-Pacific - Korea
- Seock-Ah Im (Seoul National Univ., Korea)
- Clinical Trail Collaboration across and beyond Asia-Pacific - Hong Kong
- Janice Tsang (Hong Kong Breast Oncology Group (HKBOG), Hong Kong)
- Clinical Trail Collaboration across and beyond Asia-Pacific - Japan
- Shinji Ohno (Cancer Institute Hospital, Japan)
- Clinical Trail Collaboration across and beyond Asia-Pacific - Singapore
- Yoon Sim Yap (National Cancer Centre Singapore, Singapore)
17:30-18:20
- Satellite Symposium 4
-
- Venue:
- Halla Hall
- Prognostic Diagnosis for HR+/HER2- Early Breast Cancer Patient Based on the Algorithm through the Gene Expression Signature
- Young Kee Shin (Seoul National Univ., Korea)Slide ViewVideo ViewAbstract
6Fl., squareME Bldg., 225 Bongeunsa-ro, Gangnam-gu, Seoul 06109, Korea 
+82-2-3452-7291 
+82-2-565-2434
gbcc@intercom.co.kr
www.gbcc.kr
